Skip to main navigation Skip to search Skip to main content

Safety and Quality-Of-Life (QOL) Assessments in the Open-Label, Multicenter, Phase 3b, Expanded Access Study of Everolimus in Patients with Advanced Neuroendocrine Tumors (NET)

  • Marianne Pavel
  • , Nicole Unger
  • , Ivan Borbath
  • , Sergio Ricci
  • , Tsann-Long Hwang
  • , Young Suk Park
  • , Jiri Tomasck
  • , Hussein Raef
  • , Sudsawat Laohavinij
  • , Santosh Sutradhar
  • , Lisa Jean-Louis
  • , Ashok Panneerselvam
  • , Stephen Saletan
  • , Sotirios G. Stergiopoulos
  • , Oliver Bechter

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
Pages (from-to)500-501
JournalPancreas
Volume43
Issue number3
StatePublished - 2014

Cite this